Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| PTC Therapeutics, Inc.(PTCT) | 918,846 | 875,349 | -43,497 | $74.95M | $56.71M | 8.44% | -$18.25M |
| Iovance Biotherapeutics, Inc.(IOVA) | 5,296,209 | 3,471,456 | -1,824,753 | $22.03M | $51.45M | 7.65% | +$29.41M |
| Insmed Incorporated(INSM) | 413,980 | 443,645 | +29,665 | $44.14M | $50.64M | 7.53% | +$6.50M |
| Acadia Pharmaceuticals Inc | 2,864,096 | 2,485,608 | -378,488 | $72.46M | $50.09M | 7.45% | -$22.38M |
| BioMarin Pharmaceutical Inc.(BMRN) | 682,777 | 642,455 | -40,322 | $39.07M | $38.55M | 5.73% | -$521.2K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 348,808 | 387,314 | +38,506 | $40.83M | $33.11M | 4.93% | -$7.73M |
| United Therapeutics Corporation(UTHR) | 62,587 | 58,875 | -3,712 | $33.91M | $31.90M | 4.75% | -$2.01M |
| Dyne Therapeutics, Inc.(DYN) | 1,647,521 | 1,881,927 | +234,406 | $36.59M | $30.32M | 4.51% | -$6.27M |
| Biogen Inc.(BIIB) | 140,279 | 132,918 | -7,361 | $30.31M | $30.02M | 4.47% | -$285.2K |
| Anaptysbio Inc | 603,489 | 595,264 | -8,225 | $40.74M | $29.92M | 4.45% | -$10.82M |
| CareDx, Inc.(CDNA) | 531,870 | 424,601 | -107,269 | $15.16M | $27.60M | 4.11% | +$12.44M |
| First Tracks Biotherapeutics | 603,489 | 741,097 | +137,608 | $12.14M | $26.26M | 3.91% | +$14.12M |
| Disc Medicine, Inc.(IRON) | 416,646 | 396,529 | -20,117 | $30.47M | $25.96M | 3.86% | -$4.52M |
| NovoCure Limited(NVCR) | 1,280,439 | 1,209,774 | -70,665 | $19.40M | $19.30M | 2.87% | -$102.8K |
| Bicara Therapeutics Inc | 550,408 | 689,344 | +138,936 | $16.34M | $12.83M | 1.91% | -$3.51M |
| Annexon Inc | 2,948,090 | 2,811,222 | -136,868 | $16.83M | $11.89M | 1.77% | -$4.94M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 864,986 | 596,356 | -268,630 | $18.91M | $11.21M | 1.67% | -$7.70M |
| Celldex Therapeutics, Inc.(CLDX) | 399,856 | 343,101 | -56,755 | $14.88M | $11.12M | 1.65% | -$3.76M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 596,495 | 710,029 | +113,534 | $19.92M | $10.67M | 1.59% | -$9.25M |
| Prothena Corp PlcSHS SHS | 1,143,155 | 1,129,363 | -13,792 | $11.19M | $9.46M | 1.41% | -$1.73M |
| Travere Therapeutics, Inc.(TVTX) | 167,525 | 158,946 | -8,579 | $9.52M | $9.36M | 1.39% | -$158.4K |
| Alkermes plcSHS(ALKS) | 242,560 | 203,680 | -38,880 | $12.71M | $8.25M | 1.23% | -$4.46M |
| Compass Therapeutics Inc | 5,831,813 | 7,148,673 | +1,316,860 | $12.77M | $7.43M | 1.11% | -$5.34M |
| Agios Pharmaceuticals, Inc.(AGIO) | 213,601 | 200,984 | -12,617 | $7.93M | $6.68M | 0.99% | -$1.24M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,391,382 | 1,337,217 | -54,165 | $9.48M | $6.51M | 0.97% | -$2.96M |
| Aclaris Therapeutics Inc | 1,613,430 | 1,156,396 | -457,034 | $8.54M | $6.08M | 0.90% | -$2.45M |
| Capricor Therapeutics Inc | 229,763 | 548,071 | +318,308 | $5.53M | $5.19M | 0.77% | -$342.5K |
| Align Technology Inc | 31,389 | 31,389 | 0 | $5.29M | $4.56M | 0.68% | -$731.7K |
| Newamsterdam Pharma Company ORDINARY SHARES | 44,359 | 162,874 | +118,515 | $1.50M | $3.96M | 0.59% | +$2.46M |
| Protara Therapeutics Inc | 0 | 1,035,964 | +1,035,964 | $0 | $3.16M | 0.47% | +$3.16M |
| Contineum Therapeutics IncCL A | 0 | 220,226 | +220,226 | $0 | $2.96M | 0.44% | +$2.96M |
| Edwards Lifesciences Corp | 33,640 | 33,640 | 0 | $3.04M | $2.90M | 0.43% | -$139.3K |
| Verastem, Inc.(VSTM) | 309,685 | 325,480 | +15,795 | $1.18M | $2.62M | 0.39% | +$1.44M |
| Neurocrine Biosciences, Inc.(NBIX) | 18,117 | 18,117 | 0 | $3.05M | $2.57M | 0.38% | -$483.6K |
| Sagimet Biosciences IncCOM SER A | 250,000 | 250,000 | 0 | $1.93M | $2.47M | 0.37% | +$537.5K |
| Adlai Nortye Group LtdADS | 0 | 149,490 | +149,490 | $0 | $2.39M | 0.36% | +$2.39M |
| Stoke Therapeutics, Inc.(STOK) | 84,631 | 84,631 | 0 | $2.77M | $2.20M | 0.33% | -$568.7K |
| Oruka Therapeutics, Inc.(ORKA) | 33,546 | 25,563 | -7,983 | $3.19M | $2.13M | 0.32% | -$1.06M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 39,605 | 36,949 | -2,656 | $2.16M | $2.04M | 0.30% | -$116.0K |
| Pyxis Oncology Inc | 864,277 | 864,277 | 0 | $2.60M | $2.01M | 0.30% | -$587.7K |
| Cytokinetics, Incorporated(CYTK) | 32,195 | 30,036 | -2,159 | $2.74M | $1.98M | 0.29% | -$763.0K |
| BioNTech SEADS(BNTX) | 19,614 | 19,614 | 0 | $1.83M | $1.93M | 0.29% | +$103.0K |
| Nuvation Bio Inc.CL A(NUVB) | 326,609 | 326,609 | 0 | $1.86M | $1.83M | 0.27% | -$26.1K |
| Xenon Pharmaceuticals Inc.(XENE) | 51,345 | 47,902 | -3,443 | $3.10M | $1.78M | 0.27% | -$1.32M |
| Humana Inc.(HUM) | 3,985 | 3,985 | 0 | $1.58M | $1.52M | 0.23% | -$62.4K |
| COMPASS Pathways plcADS(CMPS) | 115,616 | 115,616 | 0 | $1.64M | $1.44M | 0.21% | -$197.7K |
| Ehealth Inc | 1,482,797 | 1,431,535 | -51,262 | $2.21M | $1.02M | 0.15% | -$1.19M |
| Xeris Biopharma Holdings Inc | 104,410 | 104,410 | 0 | $826.9K | $998.2K | 0.15% | +$171.2K |
| UroGen Pharma Ltd.(URGN) | 24,500 | 24,500 | 0 | $901.6K | $995.4K | 0.15% | +$93.8K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,787 | 1,787 | 0 | $959.5K | $900.6K | 0.13% | -$59.0K |
| Cybin Inc | 0 | 72,634 | +72,634 | $0 | $892.7K | 0.13% | +$892.7K |
| Bicycle Therapeutics PlcADS | 201,890 | 188,351 | -13,539 | $856.0K | $693.1K | 0.10% | -$162.9K |
| Inspire Medical Systems, Inc.(INSP) | 8,772 | 8,772 | 0 | $391.3K | $608.4K | 0.09% | +$217.1K |
| Abeona Therapeutics Inc | 108,865 | 108,865 | 0 | $672.8K | $571.5K | 0.09% | -$101.2K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 188,807 | 188,807 | 0 | $351.2K | $313.4K | 0.05% | -$37.8K |
| Aldeyra Therapeutics Inc | 155,709 | 155,709 | 0 | $331.7K | $191.5K | 0.03% | -$140.1K |